CPSP: Chronic Postsurgical Pain

Sponsor
Gillette Children's Specialty Healthcare (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05764681
Collaborator
National Institutes of Health (NIH) (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH), University of Minnesota (Other)
500
1
70.1
7.1

Study Details

Study Description

Brief Summary

The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors for the development of chronic postsurgical pain. The main aims of the investigators are to:

  1. Quantify the trajectory of pain and opioid use in the context of orthopedic surgery in children with CP.

  2. Identify predictors for CPSP in children with CP and develop an applicable risk index.

  3. Examine relationships between perioperative pain severity and functional/mobility outcomes achieved by orthopedic surgery in children with CP.

Participants will complete:
  1. Questionnaires/Surveys via email and text message

  2. In-person Sensory Tests

  3. In-person Gait and Motion Analysis

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Chronic Postsurgical Pain in Cerebral Palsy
    Anticipated Study Start Date :
    Mar 1, 2023
    Anticipated Primary Completion Date :
    Feb 1, 2028
    Anticipated Study Completion Date :
    Jan 1, 2029

    Outcome Measures

    Primary Outcome Measures

    1. Change in Brief Pain Inventory (BPI) score from 1 week preoperative to 1, 3, 6, and 12 months postoperative [1 week preoperative, and 1, 3, 6, and 12 months postoperative]

      The BPI assesses pain location, pain intensity at worst, least, average, and right now as well as the degree to which pain interferes with activities of daily living (e.g., sleep, relationships, and mobility). Items are scored on an 11-point scale (0 = does not interfere, 10 = completely interferes) creating a total interference score ranging from 0-120. The BPI has been adapted for and tested with individuals with severe CP, resulting in excellent internal consistency (Cronbach's alpha = 0.89) and validity evidence [1, 29, 30]. The BPI will take parents/children 1-2 minutes to complete.

    Secondary Outcome Measures

    1. Dalhousie Pain Interview (DPI) [1 week preoperative, and 1, 3, 6, and 12 months postoperative]

      The DPI uses a 10-item survey to quantify pain intensity (Primary outcome variable; scored 0-10), duration (minutes/seconds in pain), and pain frequency (number of pain episodes) for each type of pain reported in the last week. The type and dose of pain-related medications is also collected. The DPI was developed to assess acute and chronic pain in children with developmental disabilities. The investigative team has considerable experience with the DPI and pain parameters have shown sensitivity to change after treatment [30, 31]. The DPI will take parents/children 5-15 minutes to complete.

    2. Numeric Rating Scale (NRS) [From Post-Operative Day (POD) 3-90]

      The NRS of pain is considered the 'gold standard' and has been widely used to quantify pain intensity (0-10 scale; 0=no pain, 10=worst possible pain). We will use the NRS specific to head, shoulders, upper arm, elbow, forearm, wrist/hand, back, hip, upper leg, knee, lower leg, ankle, and foot pain. The NRS will complement the DPI since it is joint-specific, which is a critical element to capture when assessing orthopedic outcomes. The NRS will take parents/children 3 minutes to complete.

    3. Adolescent Pediatric Pain Tool (APPT) [1 week preoperative, and 1, 3, 6, and 12 months postoperative]

      When children have pain and are able to self-report they will complete the portion of the APPT that describes pain quality (e.g., burning, itching) and temporal pattern (e.g., how pain changes over time). This information will help inform the type of pain (neuropathic, nociceptive, etc.). The APPT has demonstrated strong psychometric properties in children ages 8-17 years and has been shown to be a valid measure of postoperative pain in children. The APPT will take children 2-3 minutes to complete.

    4. SNAKE Sleep Questionnaire [1 week preoperative, and 1, 3, 6, and 12 months postoperative]

      We will also collect the SNAKE Sleep Questionnaire via parent-report, a 43-item tool that measures the sleep environment, sleep patterns, and sleep behaviors. This tool was designed specifically for individuals with severe disabilities, and individuals with CP were included in the validation sample. The SNAKE will take parents 2-5 minutes to complete.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • CP diagnosis

    • Have a scheduled lower extremity or spine orthopedic surgery

    Exclusion Criteria:
    • Non-English speaking and reading parent/guardian

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Gillette Children's Specialty Healthcare Saint Paul Minnesota United States 55101

    Sponsors and Collaborators

    • Gillette Children's Specialty Healthcare
    • National Institutes of Health (NIH)
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    • University of Minnesota

    Investigators

    • Principal Investigator: Chantel Burkitt, PhD, Gillette Children's, University of Minnesota

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Chantel Burkitt, Principal Investigator, Gillette Children's Specialty Healthcare
    ClinicalTrials.gov Identifier:
    NCT05764681
    Other Study ID Numbers:
    • STUDY00014668
    • 1R01HD108406-01A1
    First Posted:
    Mar 13, 2023
    Last Update Posted:
    Mar 13, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Chantel Burkitt, Principal Investigator, Gillette Children's Specialty Healthcare
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 13, 2023